Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Institute Of Advanced Sciences has 2 pending office actions in Biotechnology & Pharmaceuticals. The profile identifies 2 distinct examiners and 2 distinct art units, showing that the matters are handled in separate examination assignments. Portfolio review should therefore preserve consistency in the underlying scientific position while addressing each examiner’s record on its own terms.
TIEN, LUCY MINYU is the busiest examiner, with 1 pending office action. The listed examiner workload covers part of the portfolio activity, leaving another matter associated with a different examiner or art unit. Counsel should coordinate claim language and disclosure support across the matters, while tailoring prior-art arguments and amendments to each biotechnology examination pathway.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TIEN, LUCY MINYU | 1 | 59.6% | +35.9% |
| LY, KRISTINA ELISABETH | 1 | 37.5% | +100.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18352248 | Pharmaceutical Preparation for Topical Delivery of Botulinum Toxin | TIEN, LUCY MINYU | 70d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18352248 | Pharmaceutical Preparation for Topical Delivery of Botulinum Toxin | TIEN, LUCY MINYU | 70d |
| 18338054 | Multi-Epitope Vaccine Platform | LY, KRISTINA ELISABETH | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18352248 | Pharmaceutical Preparation for Topical Delivery of Botulinum Toxin | TIEN, LUCY MINYU | 1612 | §103§112 | Non-Final OA | 70d | Pending | Jul 14, 2023 |
| 18338054 | Multi-Epitope Vaccine Platform | LY, KRISTINA ELISABETH | 1671 | §112 | Final Rejection | — | Pending | Jun 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitute Of Advanced Sciences has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Lucy Minyu Tien has the most, with 1 of Institute Of Advanced Sciences's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.